March 2026 – HoyLunes : Noticias Valencia y España

The Unexpected “Hub”: Geopolitics of Clinical Innovation in the New European Architecture

March 6, 2026 Noticias Valencia - HoyLunes

How Spain became the preferred laboratory for multinationals—and why this leadership does not yet translate into industrial power. By Ehab Soltan HoyLunes – Europe is undergoing a silent redefinition of its pharmaceutical ecosystem. The regulatory reform driven by the European Commission, the progressive application of the European Health Technology Assessment (HTA) Regulation, and the consolidation of the scientific…

Spain in the New European Pharmaceutical Architecture: A Strategic Opportunity for Multinationals

March 4, 2026 Noticias Valencia - HoyLunes

How to turn EU regulatory reform into a platform for industrial and clinical leadership from Spanish subsidiaries. By Ehab Soltan HoyLunes – Europe is redefining the rules of the pharmaceutical game. The combination of EU legislative reform, the progressive implementation of the Health Technology Assessment (HTA) Regulation, and the consolidation of the European Medicines Agency’s (EMA) scientific role is…

Democracy Under Siege: The Strategy of Exclusion

March 4, 2026 Noticias Valencia - HoyLunes

A critical analysis of how the instrumentalization of “us” versus “them” erodes democratic foundations. From the logic of war to the moral boundaries of communitarianism, we explore the deliberate strategy of converting difference into a threat and the urgency of transitioning from a politics of rejection toward a culture of mutual recognition. By Claudia Benítez HoyLunes – We are…

Andalusian: The Voice That Doesn’t Have to Ask for Permission

March 4, 2026March 4, 2026 Noticias Valencia - HoyLunes

Beyond phonetics and social stigma, the Andalusian way of speaking asserts itself as a tool of pragmatic intelligence, collective memory, and identity dignity. An analysis of the expressive economy of the South, its place within the literary norm, and the cultural battle for a voice of its own that needs no subtitles. By Nuria Ruiz Fdez HoyLunes – There…

Europe, Vaccines, and Childhood Cancer: Medicine’s New Social Contract According to the EMA

March 2, 2026 Noticias Valencia - HoyLunes

From mRNA combination vaccines to targeted therapies for pediatric tumors: the EMA drives a new balance between innovation, clinical benefit, and social responsibility. By Ehab Soltan HoyLunes – From the halls of its Amsterdam headquarters, the European Medicines Agency (EMA) is doing more than just validating molecules; it is redefining the operational framework of European healthcare for the coming decade.…